Search by Drug Name or NDC

    NDC 41167-4310-04 Allegra-D Allergy and Congestion 60; 120 mg/1; mg/1 Details

    Allegra-D Allergy and Congestion 60; 120 mg/1; mg/1

    Allegra-D Allergy and Congestion is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Chattem, Inc.. The primary component is FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 41167-4310
    Product ID 41167-4310_ebb05cc9-3bff-4357-942c-d0ab0a276938
    Associated GPIs 43993002687420
    GCN Sequence Number 036868
    GCN Sequence Number Description fexofenadine/pseudoephedrine TAB ER 12H 60MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 63565
    HICL Sequence Number 016846
    HICL Sequence Number Description FEXOFENADINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Brand
    Proprietary Name Allegra-D Allergy and Congestion
    Proprietary Name Suffix n/a
    Non-Proprietary Name fexofenadine hydrochloride and pseudoephedrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 60; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Chattem, Inc.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020786
    Listing Certified Through 2024-12-31

    Package

    NDC 41167-4310-04 (41167431004)

    NDC Package Code 41167-4310-4
    Billing NDC 41167431004
    Package 2 BLISTER PACK in 1 CARTON (41167-4310-4) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2011-03-03
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b32e172a-abf5-4c17-aa39-19e517952b91 Details

    Revised: 8/2021